Welcome : Guest

Catabasis Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Catabasis Pharmaceuticals, Inc., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 4 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65978
Price: $200
Company Type: Public
Pages: 6
Date: January 2017
Market Data Tables: 4

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Duchenne Muscular Dystrophy (DMD) Disease......3
Table 1: Duchenne Muscular Dystrophy (DMD) Disease Market by Therapy in the U.S (2015) - Percentage Breakdown by No. of Patients for Exon 44, Exon 45, Exon 46, Exon 51, Exon 53, and Others......3
Table 2: Duchenne Muscular Dystrophy (DMD) Disease Market by Therapy in European Union (2015) - Percentage Breakdown by No.of Patients for Exon 44, Exon 45, Exon 46, Exon 51, Exon 53, and Others......4
Cystic Fibrosis (CF)......5
Table 3: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......5
Table 4: Drugs for Treatment of Cystic Fibrosis Market Worldwide (2015) in US$ Million......6